مباشر

CellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM FierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M BioPharma DiveLilly buys non-opioid pain drugmaker 4E BioPharma DiveExpress Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies BioPharma DiveFDA staff scrutinizes evidence supporting Moderna’s flu vaccine Endpoints NewsEdgewise to advance heart drug into Phase 3 following mid-stage data update FierceBiotechEdgewise data power rival to BMS and Cytokinetics toward phase 3 FierceBiotechiRhythm hit by cyberattack that compromised patient data, says operations unaffected FierceBiotechMerck inks $510M biobucks data generation partnership with Protillion Endpoints NewsHow to launch a telehealth business in one day Endpoints NewsLilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill PharmaVoiceCorvus CEO thinks his next blockbuster is an ITK inhibitor

Clinical OMICs ١٦ يونيو ٢٠٢٦

Adaptive Deep Brain Stimulation Improves Walking and Reduces Falls in Parkinson’s Disease

Researchers at UCSF have developed a personalized deep brain stimulation system that detects neural signals associated with each step and adjusts therapy in rea...

Researchers at UCSF have developed a personalized deep brain stimulation system that detects neural signals associated with each step and adjusts therapy in real time, improving walking stability and reducing falls in people with Parkinson’s disease. The post Adaptive Deep Brain Stimulation Improves Walking and Reduces Falls in Parkinson’s Disease appeared first on Inside Precision Medicine .